The company has not filed an annual or quarterly report since its Q1 FY2017 10-Q, filed Mar 16, 2018. Its latest SEC filing is a 8-K from Aug 3, 2026.
10-Q for Q1 FY2017, filed Mar 16, 2018
The sections below describe the company as of the FY2015 annual report.
Develops handheld breath-screening devices to detect disease and drug use for health care providers, law enforcement and other organizations.
10-K for FY2015, filed May 5, 2017We are developing a platform technology to analyze the Volatile Organic Compound signatures in a person’s breath using a handheld device…View ↗
Customers for our medical diagnostic products is expected to include health care providers such as medical doctors, nurse practitioners and…View ↗
Customers for our product will include the different areas of law enforcement as well as the different areas of professional and amateur…View ↗
Medical diagnostic customers are expected to be health care providers; narcotics-screening customers include law enforcement, sports organizations and corporations.
10-K for FY2015, filed May 5, 2017
10-Q for Q1 FY2017, filed Mar 16, 2018
−$458.6KView ↗
8-K, filed Aug 3, 2026
Additionally, On July 29, 2026, the Company entered into a Share Exchange and Acquisition Agreement (“The Merger Agreement”) with NEPTUNE…View ↗
8-K, filed Sep 13, 2023
On September 11, 2023, the Company and its control shareholder entered into an agreement to cancel the September 15, 2022 Securities…View ↗
8-K, filed Dec 2, 2022
On November 2, 2022 the Registrant engaged Haroon Imtiaz, CPA as the Registrant's new independent registered public accounting firm. The…View ↗
8-K, filed Sep 16, 2022
On September 15, the Company and its control shareholder entered into an agreement to sell all the outstanding shares of the control voting…View ↗
Loading...